Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure Life Science Investing
Medtronic to announce financial results for its third quarter of fiscal year 2026 Medical Device Investing
OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners Life Science Investing
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit Life Science Investing
Stoke Therapeutics Announces First Patient Dosed in Phase 1 Study of STK-002, a Potential Disease-Modifying Medicine for the Treatment of Autosomal Dominant Optic Atrophy Life Science Investing
